CHEPLAPHARM Adopts TraceLink MINT to Automate Global Supply Chain Operations

Event summary

  • CHEPLAPHARM Group is going live on TraceLink's Multienterprise Information Network Tower (MINT) platform on May 14, 2026.
  • The implementation will automate core supply chain processes, replacing manual workflows with real-time digital data exchange.
  • TraceLink's B2N Integrate-Once™ model allows CHEPLAPHARM to onboard partners rapidly with no subscription or setup fees.
  • MINT will act as an orchestration layer between CHEPLAPHARM's SAP environment and its global trading partners' ERP systems.
  • CHEPLAPHARM employs about 800 people worldwide and operates sites in Germany, France, Japan, Russia, and Switzerland.

The big picture

CHEPLAPHARM's adoption of TraceLink's MINT platform reflects a broader industry trend towards supply chain digitalization and automation. As pharmaceutical companies expand globally through acquisitions, the need for standardized, real-time data exchange becomes critical. This move positions CHEPLAPHARM to enhance operational efficiency and agility, while also future-proofing its supply chain for emerging AI-driven capabilities. The scalability and cost-efficiency of TraceLink's B2N Integrate-Once™ model could set a new standard for partner onboarding in the life sciences sector.

What we're watching

Integration Speed
How quickly CHEPLAPHARM can onboard and integrate its global trading partners onto the TraceLink network.
AI Readiness
Whether CHEPLAPHARM's current digitalization efforts will adequately prepare it for future agent-based intelligence capabilities.
Operational Resilience
The impact of standardized data exchange on reducing IT workload and improving long-term system scalability.